{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:09:51Z","timestamp":1765667391403},"reference-count":113,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2023,1,6]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Peptic ulcer disease (PUD) is a widespread condition that affects millions of people\neach year, with an incidence rate of 0.1%-1.5%, and has a significant impact on human health.\nA range of stimuli, such as Helicobacter pylori, non-steroidal anti-inflammatory drugs, hyperacidity,\nstress, alcohol, smoking, and idiopathic disease states, can produce a sore in the gastrointestinal\nmucosal layer. For individuals infected with H. pylori, 2%-3% remain asymptomatic\nthroughout their life. Although PUD treatments are available, genetic variations occurring in\nindividuals because of geographical dissimilarity and antibiotic resistance pose limitations. Specifically,\ninflammatory cytokine gene polymorphisms have received immense attention in recent\nyears because they appear to affect the severity and duration of stomach inflammation,\nwhich is induced by H. pylori infection, contributing to the initiation of PUD. In such a context,\nin-depth knowledge of interleukins may aid in the discovery of new targets and provide precautionary\napproaches for the treatment of PUD. This review aims to give insights into the importance\nof several interleukins that cognate with PUD and contribute to ulcer progression or\nhealing by activating or dampening the host immunity. Furthermore, the available targets with\nclinical evidence have been explored in this review.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530322666220829142124","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T07:38:57Z","timestamp":1661845137000},"page":"21-34","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring Cytokines as Potential Target in Peptic Ulcer Disease: A Systematic\nUpdate"],"prefix":"10.2174","volume":"23","author":[{"given":"Gaurav Mahesh","family":"Doshi","sequence":"first","affiliation":[{"name":"Department of Pharmacology, SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, V. M. Road, Vile Parle (W), Mumbai,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alveera Zubair","family":"Ansari","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, V. M. Road, Vile Parle (W), Mumbai,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirav Yogesh","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, V. M. Road, Vile Parle (W), Mumbai,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sankalp Ashok","family":"Gharat","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, V. M. Road, Vile Parle\n(W), Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel Pavalu","family":"Godad","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, V. M. Road, Vile Parle (W), Mumbai,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4103\/2229-5178.137819","volume":"5","author":"Vasudevan B.","year":"2014","unstructured":"Vasudevan B.; Pathophysiology and classification. Indian Dermatol Online J 2014,5(3),366","journal-title":"Indian Dermatol Online J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/1203475419858955","volume":"23","author":"Maliyar K.","year":"2019","unstructured":"Maliyar K.; Mufti A.; Syed M.; Selk A.; Dutil M.; Bunce P.E.; Alavi A.; Genital ulcer disease: A review of pathogenesis and clinical features. J Cutan Med Surg 2019,23(6),624-634","journal-title":"J Cutan Med Surg"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jtv.2013.08.001","volume":"22","author":"Akita S.","year":"2013","unstructured":"Akita S.; Houbara S.; Akatsuka M.; Hirano A.; Vascular anomalies and wounds. J Tissue Viability 2013,22(4),103-111","journal-title":"J Tissue Viability"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/00325481.2020.1795485","volume":"132","author":"Shah H.","year":"2020","unstructured":"Shah H.; Yang T.J.; Wudexi I.; Solanki S.; Patel S.; Rajan D.; Rodas A.; Dajjani M.; Chakinala R.C.; Shah P.; Sarker K.; Patel A.; Aronow W.; Trends and outcomes of peptic ulcer disease in patients with cirrhosis. Postgrad Med 2020,132(8),773-780","journal-title":"Postgrad Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.amjmed.2018.12.009","volume":"132","author":"Kavitt R.T.","year":"2019","unstructured":"Kavitt R.T.; Lipowska A.M.; Anyane-Yeboa A.; Gralnek I.M.; Diagnosis and treatment of peptic ulcer disease. Am J Med 2019,132(4),447-456","journal-title":"Am J Med"},{"key":"ref=6","unstructured":"Peptic ulcer disease: Epidemiology, etiology, and pathogenesis. Available from:   (Accessed on: 2022 Jul 8)."},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-018-0480-y","volume":"25","author":"Chmiela M.","year":"2018","unstructured":"Chmiela M.; Walczak N.; Rudnicka K.; Helicobacter pylori outer membrane vesicles involvement in the infection development and Helicobacter pylori-related diseases. J Biomed Sci 2018,25(1),1-11","journal-title":"J Biomed Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1136\/gutjnl-2019-318715","volume":"69","author":"Wong G.L.H.","year":"2020","unstructured":"Wong G.L.H.; Lau L.H.S.; Ching J.Y.L.; Tse Y.K.; Ling R.H.Y.; Wong V.W.S.; Chiu P.W.Y.; Lau J.Y.W.; Chan F.K.L.; Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: A double-blind, randomised trial. Gut 2020,69(4),652-657","journal-title":"Gut"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1111\/j.1572-0241.2002.07068.x","volume":"97","author":"Quan C.","year":"2002","unstructured":"Quan C.; Talley N.J.; Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol 2002,97(12),2950-2961","journal-title":"Am J Gastroenterol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2249.2008.03859.x","volume":"156","author":"Koussoulas V.","year":"2009","unstructured":"Koussoulas V.; Vassiliou S.; Giamarellos-Bourboulis E.J.; Tassias G.; Kotsaki A.; Barbatzas C.; Tzivras M.; Implications for a role of interleukin-23 in the pathogenesis of chronic gastritis and of peptic ulcer disease. Clin Exp Immunol 2009,156(1),97-101","journal-title":"Clin Exp Immunol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"826106","DOI":"10.3389\/fimmu.2022.826106","volume":"13","author":"Wu D.","year":"2022","unstructured":"Wu D.; Zhang Z.; Jiang X.; Du Y.; Zhang S.; Yang X.D.; Inflammasome meets centrosome: Understanding the emerging role of centrosome in controlling inflammasome activation. Front Immunol 2022,13,826106","journal-title":"Front Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/19490976.2015.1105427","volume":"6","author":"Koch K.N.","year":"2015","unstructured":"Koch K.N.; M&#xFC;ller A.; Helicobacter pylori activates the TLR2\/NLRP3\/caspase-1\/IL-18 axis to induce regulatory T-cells, establish persistent infection and promote tolerance to allergens. Gut Microbes 2015,6(6),382-387","journal-title":"Gut Microbes"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/gutjnl-2014-307175","volume":"65","author":"Ng G.Z.","year":"2016","unstructured":"Ng G.Z.; Menheniott T.R.; Every A.L.; Stent A.; Judd L.M.; Chionh Y.T.; Dhar P.; Komen J.C.; Giraud A.S.; Wang T.C.; McGuckin M.A.; Sutton P.; The MUC1 mucin protects against Helicobacter pylori pathogenesis in mice by regulation of the NLRP3 inflammasome. Gut 2016,65(7),1087-1099","journal-title":"Gut"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/1753425917738043","volume":"24","author":"Pachathundikandi S.K.","year":"2018","unstructured":"Pachathundikandi S.K.; Backert S.; Helicobacter pylori controls NLRP3 expression by regulating hsa-miR-223-3p and IL-10 in cultured and primary human immune cells. Innate Immun 2018,24(1),11-23","journal-title":"Innate Immun"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","volume":"157","author":"Lamkanfi M.","year":"2014","unstructured":"Lamkanfi M.; Dixit V.M.; Mechanisms and functions of inflammasomes. Cell 2014,157(5),1013-1022","journal-title":"Cell"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1172\/JCI79337","volume":"125","author":"Koch K.N.","year":"2015","unstructured":"Koch K.N.; Hartung M.L.; Urban S.; Kyburz A.; Bahlmann A.S.; Lind J.; Backert S.; Taube C.; M&#xFC;ller A.; Helicobacter urease-induced activation of the TLR2\/NLRP3\/IL-18 axis protects against asthma. J Clin Invest 2015,125(8),3297-3302","journal-title":"J Clin Invest"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"Liu T.","year":"2017","unstructured":"Liu T.; Zhang, L.; Joo, D.; Sun, S.C. NF-&#x3BA;B signaling in inflammation. Signal Transduct Target Ther 2017,2(1),17023","journal-title":"Signal Transduct Target Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.4049\/jimmunol.1502261","volume":"196","author":"Chen J.","year":"2016","unstructured":"Chen J.; Wang Z.; Hu X.; Chen R.; Romero-Gallo J.; Peek R.M.; Chen L.F.; BET inhibition attenuates Helicobacter pylori - induced inflammatory response by suppressing inflammatory gene transcription and enhancer activation. J Immunol 2016,196(10),4132-4142","journal-title":"J Immunol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3164\/jcbn.10-79","volume":"48","year":"2011","unstructured":"J Clin Biochem Nutr 2011,48(2),107-111","journal-title":"J Clin Biochem Nutr"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5152\/eurasianjmed.2018.0010","volume":"50","author":"Gunaydin C.","year":"2018","unstructured":"Gunaydin C.; Bilge S.S.; Effects of nonsteroidal anti-inflammatory drugs at the molecular level. Eurasian J Med 2018,50(2),116-121","journal-title":"Eurasian J Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fimmu.2018.00074","volume":"9","author":"Berkowitz L.","year":"2018","unstructured":"Berkowitz L.; Schultz B.M.; Salazar G.A.; Pardo-Roa C.; Sebasti&#xE1;n V.P.; &#xC1;lvarez-Lobos M.M.; Bueno S.M.; Impact of cigarette smoking on the gastrointestinal tract inflammation: Opposing effects in Crohn\u2019s disease and ulcerative colitis. Front Immunol 2018,9,74","journal-title":"Front Immunol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.oraloncology.2016.10.001","volume":"62","author":"L&#xF3;pez-L&#xE1;zaro M.","year":"2016","unstructured":"L&#xF3;pez-L&#xE1;zaro M.; A local mechanism by which alcohol consumption causes cancer. Oral Oncol 2016,62,149-152","journal-title":"Oral Oncol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.drugalcdep.2017.11.013","volume":"183","author":"Guill&#xE9;n-Mancina E.","year":"2018","unstructured":"Guill&#xE9;n-Mancina E.; Calder&#xF3;n-Monta&#xF1;o J.M.; L&#xF3;pez-L&#xE1;zaro M.; Avoiding the ingestion of cytotoxic concentrations of ethanol may reduce the risk of cancer associated with alcohol consumption. Drug Alcohol Depend 2018,183,201-204","journal-title":"Drug Alcohol Depend"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1177\/0148607190014006615","volume":"14","author":"Auguste L.J.","year":"1990","unstructured":"Auguste L.J.; Lackner R.; Ratner L.; Stein T.A.; Bailey B.; Prevention of stress-induced erosive gastritis by parenteral administration of arachidonic acid. JPEN J Parenter Enteral Nutr 1990,14(6),615-617","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12876-016-0554-9","volume":"16","author":"Deding U.","year":"2016","unstructured":"Deding U.; Ejlskov L.; Grabas M.P.K.; Nielsen B.J.; Torp-Pedersen C.; B&#xF8;ggild H.; Perceived stress as a risk factor for peptic ulcers: A register-based cohort study. BMC Gastroenterol HYPERLINK 2016,16(1),140","journal-title":"BMC Gastroenterol"},{"key":"ref=26","author":"Megha R.","year":"2022","unstructured":"Megha R.; Farooq U.; Lopez P.P.;  Stress-Induced Gastritis; StatPearls Internet 2022","journal-title":"Stress-Induced Gastritis; StatPearls Internet"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"66700","DOI":"10.18632\/oncotarget.11449","volume":"7","author":"Hu Z.","year":"2016","unstructured":"Hu Z.; Zhang Y.; Li Z.; Yu Y.; Kang W.; Han Y.; Geng X.; Ge S.; Sun Y.; Effect of Helicobacter pylori infection on chronic periodontitis by the change of microecology and inflammation. Oncotarget 2016,7(41),66700-66712","journal-title":"Oncotarget"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e12501","DOI":"10.1111\/hel.12501","volume":"23","author":"Bassagh A.","year":"2018","unstructured":"Bassagh A.; Hayatbakhsh Abasi M.; Larussa T.; Ghazizadeh M.; Nemati M.; Mirkamandar E.; Jafarzadeh A.; Diminished circulating concentration of interleukin-35 in Helicobacter pylori -infected patients with peptic ulcer: Its association with FOXP3 gene polymorphism, bacterial virulence factor CagA, and gender of patients. Helicobacter 2018,23(4),e12501","journal-title":"Helicobacter"},{"key":"ref=29","first-page":"00121","volume":"4","author":"Gulati K.","year":"2016","unstructured":"Gulati K.; Guhathakurta S.; Joshi J.; Rai N.; Ray A.; Cytokines and their role in health and disease: A brief overview. MOJ Immunol 2016,4(2),00121","journal-title":"MOJ Immunol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2174\/1389450121666201027124625","volume":"22","author":"Doshi G.","year":"2021","unstructured":"Doshi G.; Thakkar A.; Deciphering role of cytokines for therapeutic strategies against rheumatoid arthritis. Curr Drug Targets 2021,22(7),803-815","journal-title":"Curr Drug Targets"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"109393","DOI":"10.1016\/j.compositesb.2021.109393","volume":"227","author":"Qi C.","year":"2021","unstructured":"Qi C.; Jiang F.; Yang S.; Advanced honeycomb designs for improving mechanical properties: A review. Compos, Part B Eng 2021,227,109393","journal-title":"Compos, Part B Eng"},{"key":"ref=32","author":"Mu&#xF1;oz-Carrillo J.L.","year":"2018","unstructured":"Mu&#xF1;oz-Carrillo J.L.; Contreras-Cordero J.F.; Guti&#xE9;rrez-Coronado O.; Villalobos-Guti&#xE9;rrez P.T.; Ramos-Gracia L.G.; Hern&#xE1;ndez-Reyes V.E.;  Immune Response Activation and Immunomodulation 2018","journal-title":"Immune Response Activation and Immunomodulation"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3389\/fimmu.2015.00466","volume":"6","author":"Booth J.S.","year":"2015","unstructured":"Booth J.S.; Salerno-Goncalves R.; Blanchard T.G.; Patil S.A.; Kader H.A.; Safta A.M.; Morningstar L.M.; Czinn S.J.; Greenwald B.D.; Sztein M.B.; Mucosal-associated invariant T cells in the human gastric mucosa and blood: Role in Helicobacter pylori infection. Front Immunol 2015,6,466","journal-title":"Front Immunol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cellsig.2018.10.005","volume":"53","author":"Jenei-Lanzl Z.","year":"2019","unstructured":"Jenei-Lanzl Z.; Meurer A.; Zaucke F.; Interleukin-1&#x3B2; signaling in osteoarthritis - chondrocytes in focus. Cell Signal 2019,53,212-223","journal-title":"Cell Signal"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","volume":"139","author":"Cai Y.","year":"2019","unstructured":"Cai Y.; Xue F.; Quan C.; Qu M.; Liu N.; Zhang Y.; Fleming C.; Hu X.; Zhang H.; Weichselbaum R.; Fu Y.; Tieri D.; Rouchka E.C.; Zheng J.; Yan J.; A critical role of the IL-1&#x3B2;\u2013IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. J Invest Dermatol 2019,139(1),146-156","journal-title":"J Invest Dermatol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11892-014-0553-6","volume":"14","author":"Rosenzwajg M.","year":"2014","unstructured":"Rosenzwajg M.; Churlaud G.; Hartemann A.; Klatzmann D.; Interleukin 2 in the pathogenesis and therapy of type 1 diabetes. Curr Diab Rep 2014,14(12),553","journal-title":"Curr Diab Rep"},{"key":"ref=37","first-page":"1100","volume":"48","author":"Guo Q.","year":"2016","unstructured":"Guo Q.; Chen X.Y.; Su Y.; Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus. Beijing Da Xue Xue Bao 2016,48(6),1100-1104","journal-title":"Beijing Da Xue Xue Bao"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/ITT.S214139","volume":"9","author":"Vijayakumar S.","year":"2020","unstructured":"Vijayakumar S.; Viswanathan S.; Aghoram R.; Idiopathic CD4 lymphocytopenia: Current insights. ImmunoTargets Ther 2020,9,79-93","journal-title":"ImmunoTargets Ther"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/1440-1681.12946","volume":"45","author":"Dong C.","year":"2018","unstructured":"Dong C.; Fu T.; Ji J.; Li Z.; Gu Z.; The role of interleukin-4 in rheumatic diseases. Clin Exp Pharmacol Physiol 2018,45(8),747-754","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/bjd.17869","volume":"181","author":"Akinlade B.","year":"2019","unstructured":"Akinlade B.; Guttman-Yassky E.; Bruin-Weller M.; Simpson E.L.; Blauvelt A.; Cork M.J.; Prens E.; Asbell P.; Akpek E.; Corren J.; Bachert C.; Hirano I.; Weyne J.; Korotzer A.; Chen Z.; Hultsch T.; Zhu X.; Davis J.D.; Mannent L.; Hamilton J.D.; Teper A.; Staudinger H.; Rizova E.; Pirozzi G.; Graham N.M.H.; Shumel B.; Ardeleanu M.; Wollenberg A.; Conjunctivitis in dupilumab clinical trials. Br J Dermatol 2019,181(3),459-473","journal-title":"Br J Dermatol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","volume":"37","author":"Kumari N.","year":"2016","unstructured":"Kumari N.; Dwarakanath B.S.; Das A.; Bhatt A.N.; Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol 2016,37(9),11553-11572","journal-title":"Tumour Biol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"822091","DOI":"10.3389\/fgene.2022.822091","volume":"13","author":"Yang Y.","year":"2022","unstructured":"Yang Y.; Xiao J.; Tang L.; Wang B.; Sun X.; Xu Z.; Liu L.; Shi S.; Effects of IL-6 polymorphisms on individual susceptibility to allergic diseases: A systematic review and meta-analysis. Front Genet 2022,13,822091","journal-title":"Front Genet"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"104315","DOI":"10.1016\/j.neuint.2018.10.012","volume":"130","author":"Araki M.","year":"2019","unstructured":"Araki M.; Blockade of IL-6 signaling in neuromyelitis optica. Neurochem Int 2019,130,104315","journal-title":"Neurochem Int"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.archoralbio.2018.09.015","volume":"96","author":"Azab N.A.","year":"2018","unstructured":"Azab N.A.; Abd El Salam L.; Ahmed E.; El Sharkawy M.; ElSharkawy A.; El Asheiry S.G.; Interferon gamma and interleukin 8 gene polymorphisms in patients with hepatitis C virus related oral lichen planus. Arch Oral Biol 2018,96,189-194","journal-title":"Arch Oral Biol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1159\/000512965","volume":"182","author":"Murata S.","year":"2021","unstructured":"Murata S.; Kaneko S.; Morita E.; Interleukin-8 Levels in the stratum corneum as a biomarker for monitoring therapeutic effect in atopic dermatitis patients. Int Arch Allergy Immunol 2021,182(7),592-606","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13223-019-0332-7","volume":"15","author":"Grzanka R.","year":"2019","unstructured":"Grzanka R.; Damasiewicz-Bodzek A.; Kasperska-Zajac A.; Tumor necrosis factor-alpha and Fas\/Fas ligand signaling pathways in chronic spontaneous urticaria. Allergy Asthma Clin Immunol 2019,15(1),15","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.ejim.2019.04.012","volume":"64","author":"Dima A.","year":"2019","unstructured":"Dima A.; Pricopi I.; Balanescu E.; Balanescu P.; Baicus C.; Interleukin 10 related to lymphopenia in lupus. Eur J Intern Med 2019,64,e9-e10","journal-title":"Eur J Intern Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.clinthera.2017.01.030","volume":"39","author":"Kumar S.","year":"2017","unstructured":"Kumar S.; Shukla R.; Ranjan P.; Kumar A.; Interleukin-10: A compelling therapeutic target in patients with irritable bowel syndrome. Clin Ther 2017,39(3),632-643","journal-title":"Clin Ther"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/iub.1637","volume":"69","author":"Tabrez S.","year":"2017","unstructured":"Tabrez S.; Ali M.; Jabir N.R.; Firoz C.K.; Ashraf G.M.; Hindawi S.; Damanhouri G.A.; Nabil Alama M.; A putative association of interleukin-10 promoter polymorphisms with cardiovascular disease. IUBMB Life 2017,69(7),522-527","journal-title":"IUBMB Life"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1620\/tjem.247.87","volume":"247","author":"Li Y.","year":"2019","unstructured":"Li Y.; Zhou Y.; Interleukin-17: The role for pathological angiogenesis in ocular neovascular diseases. Tohoku J Exp Med 2019,247(2),87-98","journal-title":"Tohoku J Exp Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41584-018-0044-2","volume":"14","author":"Taams L.S.","year":"2018","unstructured":"Taams L.S.; Steel K.J.A.; Srenathan U.; Burns L.A.; Kirkham B.W.; IL-17 in the immunopathogenesis of spondyloarthritis. Nat Rev Rheumatol 2018,14(8),453-466","journal-title":"Nat Rev Rheumatol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"577071","DOI":"10.1016\/j.jneuroim.2019.577071","volume":"337","author":"Moaaz M.","year":"2019","unstructured":"Moaaz M.; Youssry S.; Elfatatry A.; El Rahman M.A.; Th17\/Treg cells imbalance and their related cytokines (IL-17, IL-10 and TGF-&#x3B2;) in children with autism spectrum disorder. J Neuroimmunol 2019,337,577071","journal-title":"J Neuroimmunol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00403-016-1638-7","volume":"308","author":"Balato A.","year":"2016","unstructured":"Balato A.; Raimondo A.; Balato N.; Ayala F.; Lembo S.; Interleukin-33: Increasing role in dermatological conditions. Arch Dermatol Res 2016,308(5),287-296","journal-title":"Arch Dermatol Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/ijms18040783","volume":"18","author":"Chen W.Y.","year":"2017","unstructured":"Chen W.Y.; Li L.C.; Yang J.L.; Emerging roles of IL-33\/ST2 axis in renal diseases. Int J Mol Sci 2017,18(4),783","journal-title":"Int J Mol Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.3390\/ijms20236008","volume":"20","author":"Kany S.","year":"2019","unstructured":"Kany S.; Vollrath J.T.; Relja B.; Cytokines in inflammatory disease. Int J Mol Sci 2019,20(23),6008","journal-title":"Int J Mol Sci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3233\/JAD-200711","volume":"78","author":"Torres-Acosta N.","year":"2020","unstructured":"Torres-Acosta N.; O\u2019Keefe J.H.; O\u2019Keefe E.L.; Isaacson R.; Small G.; Therapeutic potential of TNF-&#x3B1; inhibition for Alzheimer\u2019s disease prevention. J Alzheimers Dis 2020,78(2),619-626","journal-title":"J Alzheimers Dis"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1517\/14712598.2015.1044434","volume":"15","author":"Felice C.","year":"2015","unstructured":"Felice C.; Marzo M.; Pugliese D.; Papa A.; Rapaccini G.L.; Guidi L.; Armuzzi A.; Therapeutic drug monitoring of anti-TNF-&#x3B1; agents in inflammatory bowel diseases. Expert Opin Biol Ther 2015,15(8),1107-1117","journal-title":"Expert Opin Biol Ther"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/14728222.2017.1258402","volume":"21","author":"Wang Y.","year":"2017","unstructured":"Wang Y.; Zhang J.; Luo P.; Zhu J.; Feng J.; Zhang H.L.; Tumor necrosis factor-&#x3B1; in Guillain-Barr&#xE9; syndrome, friend or foe? Expert Opin Ther Targets 2017,21(1),103-112","journal-title":"Expert Opin Ther Targets"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.disamonth.2018.09.011","volume":"65","author":"Hegde R.","year":"2019","unstructured":"Hegde R.; Awan K.H.; Effects of periodontal disease on systemic health. Dis Mon 2019,65(6),185-192","journal-title":"Dis Mon"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40249-020-00666-7","volume":"9","author":"Lin Z.Q.","year":"2020","unstructured":"Lin Z.Q.; Lin G.Y.; He W.W.; Zhang C.; Zhang R.; Li Y.D.; Wang F.; Qin Y.; Duan L.; Zhao D.D.; Qu X.J.; Gao H.; Jiang H.; IL-6 and INF-&#x3B3; levels in patients with brucellosis in severe epidemic region, Xinjiang, China. Infect Dis Poverty 2020,9(1),47","journal-title":"Infect Dis Poverty"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"14525","DOI":"10.1038\/s41598-020-71371-6","volume":"10","author":"Chen J.","year":"2020","unstructured":"Chen J.; Yue Y.; Wang L.; Deng Z.; Yuan Y.; Zhao M.; Yuan Z.; Tan C.; Cao Y.; Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease. Sci Rep 2020,10(1),14525","journal-title":"Sci Rep"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41232-019-0101-5","volume":"39","author":"Kaneko N.","year":"2019","unstructured":"Kaneko N.; Kurata M.; Yamamoto T.; Morikawa S.; Masumoto J.; The role of interleukin-1 in general pathology. Inflamm Regen 2019,39(1),1-16","journal-title":"Inflamm Regen"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bjid.2018.06.005","volume":"22","author":"Rech T.F.","year":"2018","unstructured":"Rech T.F.; Mazzoleni L.E.; Mazzoleni F.; Francesconi C.F.M.; Sander G.B.; Michita R.T.; Nabinger D.D.; Milbradt T.C.; Torresini R.J.S.; Simon D.; Helicobacter pylori eradication: Influence of interleukin-1beta \u201331 C\/T polymorphism. Braz J Infect Dis 2018,22(4),311-316","journal-title":"Braz J Infect Dis"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrgastro.2014.99","volume":"11","author":"Malfertheiner P.","year":"2014","unstructured":"Malfertheiner P.; Link A.; Selgrad M.; Helicobacter pylori: Perspectives and time trends. Nat Rev Gastroenterol Hepatol 2014,11(10),628-638","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1751-2980.2009.00380.x","volume":"10","author":"Shanks A.M.","year":"2009","unstructured":"Shanks A.M.; El-Omar E.M.; Helicobacter pylori infection, host genetics and gastric cancer. J Dig Dis 2009,10(3),157-164","journal-title":"J Dig Dis"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"e0176463","DOI":"10.1371\/journal.pone.0176463","volume":"12","author":"Ma J.","year":"2017","unstructured":"Ma J.; Wu D.; Hu X.; Li J.; Cao M.; Dong W.; Associations between cytokine gene polymorphisms and susceptibility to Helicobacter pylori infection and Helicobacter pylori related gastric cancer, peptic ulcer disease: A meta-analysis. PLoS One 2017,12(4),e0176463","journal-title":"PLoS One"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1084\/jem.28.2.223","volume":"28","author":"Cooke J.V.","year":"1918","unstructured":"Cooke J.V.; Whipple G.H.; Proteose intoxications and injury of body protein. J Exp Med 1918,28(2),223-241","journal-title":"J Exp Med"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1210\/js.2019-00053","volume":"3","author":"Johnson J.D.","year":"2019","unstructured":"Johnson J.D.; Barnard D.F.; Kulp A.C.; Mehta D.M.; Neuroendocrine regulation of brain cytokines after psychological stress. J Endocr Soc 2019,3(7),1302-1320","journal-title":"J Endocr Soc"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3748\/wjg.v16.i10.1188","volume":"16","author":"Sugimoto M.","year":"2010","unstructured":"Sugimoto M.; Yamaoka Y.; Furuta T.; Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J Gastroenterol 2010,16(10),1188-1200","journal-title":"World J Gastroenterol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S1734-1140(13)70971-X","volume":"65","author":"Moezi L.","year":"2013","unstructured":"Moezi L.; Heidari R.; Amirghofran Z.; Nekooeian A.A.; Monabati A.; Dehpour A.R.; Enhanced anti-ulcer effect of pioglitazone on gastric ulcers in cirrhotic rats: The role of nitric oxide and IL-1&#x3B2;. Pharmacol Rep 2013,65(1),134-143","journal-title":"Pharmacol Rep"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"628","DOI":"10.4236\/fns.2011.26088","volume":"2","author":"Abdul-Aziz K.K.","year":"2011","unstructured":"Abdul-Aziz K.K.; Comparative evaluation of the anti-ulcer activity of curcumin and omeprazole during the acute phase of gastric ulcer-efficacy of curcumin in gastric ulcer prevention against omeprazole. Food Nutr Sci 2011,2(6),628-640","journal-title":"Food Nutr Sci"},{"key":"ref=72","first-page":"1973","volume":"10","author":"Albaayit S.F.A.","year":"2016","unstructured":"Albaayit S.F.A.; Abba Y.; Abdullah R.; Abdullah N.; Prophylactic effects of Clausena excavata Burum. f. leaf extract in ethanol-induced gastric ulcers. Drug Des Devel Ther 2016,10,1973","journal-title":"Drug Des Devel Ther"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jmii.2015.03.002","volume":"50","author":"Ramis I.B.","year":"2017","unstructured":"Ramis I.B.; Vianna J.S.; Gon&#xE7;alves C.V.; von Groll A.; Dellagostin O.A.; da Silva P.E.A.; Polymorphisms of the IL-6, IL-8 and IL-10 genes and the risk of gastric pathology in patients infected with Helicobacter pylori. J Microbiol Immunol Infect 2017,50(2),153-159","journal-title":"J Microbiol Immunol Infect"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/147323000303100202","volume":"31","author":"Matsuo K.","year":"2003","unstructured":"Matsuo K.; Oka M.; Murase K.; Soda H.; Isomoto H.; Takeshima F.; Mizuta Y.; Murata I.; Kohno S.; Expression of interleukin 6 and its receptor in human gastric and colorectal cancers. J Int Med Res 2003,31(2),69-75","journal-title":"J Int Med Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nm1282","volume":"11","author":"Jenkins B.J.","year":"2005","unstructured":"Jenkins B.J.; Grail D.; Nheu T.; Najdovska M.; Wang B.; Waring P.; Inglese M.; McLoughlin R.M.; Jones S.A.; Topley N.; Baumann H.; Judd L.M.; Giraud A.S.; Boussioutas A.; Zhu H.J.; Ernst M.; Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-&#x3B2; signaling. Nat Med 2005,11(8),845-852","journal-title":"Nat Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"4","DOI":"10.18821\/1560-9529-2019-24-1-4-10","volume":"24","author":"Belaia O.F.","year":"2019","unstructured":"Belaia O.F.; Gutkin D.C.; Volchkova E.V.; Sundukova A.N.; Kareva E.N.; Kochina N.A.; Krasnoshchok E.V.; Maloletneva N.V.; Shabalina O.Y.; Tuaeva A.O.; The levels of IL-4 and IL-8 in serum of patients with chronic gastritis and ulcerative disease of stomach and duodenum. Epidemiol Infect Dis 2019,24(1),4-10","journal-title":"Epidemiol Infect Dis"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13099-014-0041-1","volume":"6","author":"Siddique I.","year":"2014","unstructured":"Siddique I.; Al-Qabandi A.; Al-Ali J.; Alazmi W.; Memon A.; Mustafa A.S.; Association between Helicobacter pylori genotypes and severity of chronic gastritis, peptic ulcer disease and gastric mucosal interleukin-8 levels: Evidence from a study in the Middle East. Gut Pathog 2014,6(1),41","journal-title":"Gut Pathog"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","volume":"226","author":"Mosser D.M.","year":"2008","unstructured":"Mosser D.M.; Zhang X.; Interleukin-10: New perspectives on an old cytokine. Immunol Rev 2008,226(1),205-218","journal-title":"Immunol Rev"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","volume":"29","author":"Ouyang W.","year":"2011","unstructured":"Ouyang W.; Rutz S.; Crellin N.K.; Valdez P.A.; Hymowitz S.G.; Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 2011,29(1),71-109","journal-title":"Annu Rev Immunol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/prd.12083","volume":"69","author":"Zenobia C.","year":"2015","unstructured":"Zenobia C.; Hajishengallis G.; Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 2000 2015,69(1),142-159","journal-title":"Periodontol 2000"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/mi.2009.138","volume":"3","author":"Wills-Karp M.","year":"2010","unstructured":"Wills-Karp M.; Nathan A.; Page K.; Karp C.L.; New insights into innate immune mechanisms underlying allergenicity. Mucosal Immunol 2010,3(2),104-110","journal-title":"Mucosal Immunol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/154405910808700908","volume":"87","author":"Gaffen S.L.","year":"2008","unstructured":"Gaffen S.L.; Hajishengallis G.; A new inflammatory cytokine on the block: Re-thinking periodontal disease and the Th1\/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 2008,87(9),817-828","journal-title":"J Dent Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1479-5876-9-111","volume":"9","author":"Liu B.","year":"2011","unstructured":"Liu B.; Wei L.; Meyerle C.; Tuo J.; Sen H.N.; Li Z.; Chakrabarty S.; Agron E.; Chan C.C.; Klein M.L.; Chew E.; Ferris F.; Nussenblatt R.B.; Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med 2011,9(1),111","journal-title":"J Transl Med"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.4049\/jimmunol.1200385","volume":"188","author":"Griffin G.K.","year":"2012","unstructured":"Griffin G.K.; Newton G.; Tarrio M.L.; Bu D.; Maganto-Garcia E.; Azcutia V.; Alcaide P.; Grabie N.; Luscinskas F.W.; Croce K.J.; Lichtman A.H.; IL-17 and TNF-&#x3B1; sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol 2012,188(12),6287-6299","journal-title":"J Immunol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","volume":"27","author":"Dinarello C.A.","year":"2009","unstructured":"Dinarello C.A.; Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009,27(1),519-550","journal-title":"Annu Rev Immunol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"28971","DOI":"10.1074\/jbc.M114.577429","volume":"289","author":"Liu X.","year":"2014","unstructured":"Liu X.; He F.; Pang R.; Zhao D.; Qiu W.; Shan K.; Zhang J.; Lu Y.; Li Y.; Wang Y.; Interleukin-17 (IL-17)-induced microRNA 873 (miR-873) contributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin-editing enzyme. J Biol Chem 2014,289(42),28971-28986","journal-title":"J Biol Chem"},{"key":"ref=87","first-page":"1388","volume":"19","author":"Li N.","year":"2019","unstructured":"Li N.; Wang J.; Yu W.; Dong K.; You F.; Si B.; Tang B.; Zhang Y.; Wang T.; Qiao B.; MicroRNA 146a inhibits the inflammatory responses induced by interleukin 17A during the infection of Helicobacter pylori. Mol Med Rep 2019,19(2),1388-1395","journal-title":"Mol Med Rep"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/ni.2055","volume":"12","author":"Ruland J.","year":"2011","unstructured":"Ruland J.; Return to homeostasis: Downregulation of NF-&#x3BA;B responses. Nat Immunol 2011,12(8),709-714","journal-title":"Nat Immunol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/toxins13050315","volume":"13","author":"Dewayani A.","year":"2021","unstructured":"Dewayani A.; Fauzia K.A.; Alfaray R.I.; Waskito L.A.; Doohan D.; Rezkitha Y.A.A.; Abdurachman A.; Kobayashi T.; I\u2019tishom R.; Yamaoka Y.; Miftahussurur M.; The roles of IL-17, IL-21, and IL-23 in the Helicobacter pylori infection and gastrointestinal inflammation: A review. Toxins (Basel) 2021,13(5),315","journal-title":"Toxins (Basel)"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10787-017-0380-x","volume":"26","author":"Li C.Y.","year":"2018","unstructured":"Li C.Y.; Wu C.; Therapy with omeprazole modulates regulatory T cell\/T helper 17 immune response in children with duodenal ulcers. Inflammopharmacology 2018,26(2),337-347","journal-title":"Inflammopharmacology"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/cells8101290","volume":"8","author":"Kuo C.J.","year":"2019","unstructured":"Kuo C.J.; Chen C.Y.; Lo H.R.; Feng C.L.; Wu H.Y.; Huang M.Z.; Liao T.N.; Chen Y.A.; Lai C.H.; Helicobacter pylori induces IL-33 production and recruits ST-2 to lipid rafts to exacerbate inflammation. Cells 2019,8(10),1290","journal-title":"Cells"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4292\/wjgpt.v7.i1.126","volume":"7","author":"Pay&#xE3;o S.L.M.","year":"2016","unstructured":"Pay&#xE3;o S.L.M.; Rasmussen L.T.; Helicobacter pylori and its reservoirs: A correlation with the gastric infection. World J Gastrointest Pharmacol Ther 2016,7(1),126-132","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"817237","DOI":"10.3389\/fphar.2022.817237","volume":"13","author":"Morningstar-Wright L.","year":"2022","unstructured":"Morningstar-Wright L.; Czinn S.J.; Piazuelo M.B.; Banerjee A.; Godlewska R.; Blanchard T.G.; The TNF-alpha inducing protein is associated with gastric inflammation and hyperplasia in a murine model of Helicobacter pylori infection. Front Pharmacol 2022,13(Feb),817237","journal-title":"Front Pharmacol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1515\/bmc-2020-0006","volume":"11","author":"Kak G.","year":"2020","unstructured":"Kak G.; Tiwari B.K.; Singh Y.; Natarajan K.; Regulation of Interferon-&#x3B3; receptor (IFN-&#x3B3;R) expression in macrophages during Mycobacterium tuberculosis infection. Biomol Concepts 2020,11(1),76-85","journal-title":"Biomol Concepts"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"143941","DOI":"10.1155\/2015\/143941","volume":"2015","author":"Essadik A.","year":"2015","unstructured":"Essadik A.; Jouhadi H.; Rhouda T.; Polymorphisms of tumor necrosis factor alpha in Moroccan patients with gastric pathology: New single-nucleotide polymorphisms in TNF-&#x3B1;\u2212 193. Mediators Inflamm 2015,2015,143941","journal-title":"Mediators Inflamm"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5455\/njppp.2018.8.0309317072017","volume":"8","author":"Chauhan I.","year":"2018","unstructured":"Chauhan I.; Agrawal S.; Goel R.; Status of inflammatory markers and growth factor in gastric ulcer protective effects of Punica granatum L. peel extract in rat. Natl J Physiol Pharm Pharmacol 2018,8(1),1","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"116607","DOI":"10.1016\/j.lfs.2019.116607","volume":"232","author":"Haghi Aminjan H.","year":"2019","unstructured":"Haghi Aminjan H.; Abtahi S.R.; Hazrati E.; Chamanara M.; Jalili M.; Paknejad B.; Targeting of oxidative stress and inflammation through ROS\/NF-kappaB pathway in phosphine-induced hepatotoxicity mitigation. Life Sci 2019,232(Sep),116607","journal-title":"Life Sci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"104846","DOI":"10.1016\/j.phrs.2020.104846","volume":"157","author":"Liang X.","year":"2020","unstructured":"Liang X.; Wang S.; Wang L.; Ceylan A.F.; Ren J.; Zhang Y.; Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission. Pharmacol Res 2020,157(Jul),104846","journal-title":"Pharmacol Res"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3389\/fphys.2020.00694","volume":"11","author":"Sharifi-Rad M.","year":"2020","unstructured":"Sharifi-Rad M.; Anil Kumar N.V.; Zucca P.; Varoni E.M.; Dini L.; Panzarini E.; Rajkovic J.; Tsouh Fokou P.V.; Azzini E.; Peluso I.; Prakash Mishra A.; Nigam M.; El Rayess Y.; Beyrouthy M.E.; Polito L.; Iriti M.; Martins N.; Martorell M.; Docea A.O.; Setzer W.N.; Calina D.; Cho W.C.; Sharifi-Rad J.; Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases. Front Physiol 2020,11,694","journal-title":"Front Physiol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jcmgh.2017.02.002","volume":"3","author":"Butcher L.D.","year":"2017","unstructured":"Butcher L.D.; den Hartog G.; Ernst P.B.; Crowe S.E.; Oxidative stress resulting from Helicobacter pylori infection contributes to gastric carcinogenesis. Cell Mol Gastroenterol Hepatol 2017,3(3),316","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref=101","unstructured":"Introduction and importance of medicinal plants and herbs | National Health Portal of India. Available from:  (Accessed on: 2022 Jul 8)."},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1016\/j.bbagen.2013.03.013","volume":"1830","author":"Yadav S.K.","year":"2013","unstructured":"Yadav S.K.; Adhikary B.; Bandyopadhyay S.K.; Chattopadhyay S.; Inhibition of TNF-&#x3B1; and NF-&#x3BA;B and JNK pathways accounts for the prophylactic action of the natural phenolic, allylpyrocatechol against indomethacin gastropathy. Biochim Biophys Acta, Gen Subj 2013,1830(6),3776-3786","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1002\/ptr.5210","volume":"28","author":"Paturi G.","year":"2014","unstructured":"Paturi G.; Butts C.A.; Bentley-Hewitt K.L.; McGhie T.K.; Saleh Z.S.; McLeod A.; Apple polyphenol extracts protect against aspirin-induced gastric mucosal damage in rats. Phytother Res 2014,28(12),1846-1854","journal-title":"Phytother Res"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/ars.2011.4232","volume":"16","author":"Sharma A.V.","year":"2012","unstructured":"Sharma A.V.; Ganguly K.; Paul S.; Maulik N.; Swarnakar S.; Curcumin heals indomethacin-induced gastric ulceration by stimulation of angiogenesis and restitution of collagen fibers via VEGF and MMP-2 mediated signaling. Antioxid Redox Signal 2012,16(4),351-362","journal-title":"Antioxid Redox Signal"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"110075","DOI":"10.1016\/j.biopha.2020.110075","volume":"126","author":"Zhou D.","year":"2020","unstructured":"Zhou D.; Yang Q.; Tian T.; Chang Y.; Li Y.; Duan L.R.; Li H.; Wang S.W.; Gastroprotective effect of gallic acid against ethanol-induced gastric ulcer in rats: Involvement of the Nrf2\/HO-1 signaling and anti-apoptosis role. Biomed Pharmacother 2020,126,110075","journal-title":"Biomed Pharmacother"},{"key":"ref=106","first-page":"740687","volume":"2011","author":"Cuevas V.M.","year":"2011","unstructured":"Cuevas V.M.; Calzado Y.R.; Guerra Y.P.; Yera A.O.; Despaigne S.J.; Ferreiro R.M.; Effects of grape seed extract, vitamin C, and vitamin e on ethanol- and aspirin-induced ulcers. Adv Pharmacol Sci 2011,2011,740687","journal-title":"Adv Pharmacol Sci"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/136932","volume":"2013","author":"Farzaei M.H.","year":"2013","unstructured":"Farzaei M.H.; Shams-Ardekani M.R.; Abbasabadi Z.; Rahimi R.; Scientific evaluation of edible fruits and spices used for the treatment of peptic ulcer in traditional Iranian medicine. ISRN Gastroenterol 2013,2013,1-12","journal-title":"ISRN Gastroenterol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s00210-020-01894-2","volume":"393","author":"do Nascimento R.F.","year":"2020","unstructured":"do Nascimento R.F.; de Oliveira Formiga R.; Machado F.D.F.; de Sales I.R.P.; de Lima G.M.; Alves J&#xFA;nior E.B.; Rosmarinic acid prevents gastric ulcers via sulfhydryl groups reinforcement, antioxidant and immunomodulatory effects. Naunyn Schmiedebergs Arch Pharmacol 2020,393(12),2265-2278","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/antiox8110512","volume":"8","author":"Zaghlool S.S.","year":"2019","unstructured":"Zaghlool S.S.; Abo-Seif A.A.; Rabeh M.A.; Abdelmohsen U.R.; Messiha B.A.S.; Gastro-protective and anti-oxidant potential of Althaea officinalis and Solanum nigrum on pyloric ligation\/indomethacin-induced ulceration in rats. Antioxidants 2019,8(11),512","journal-title":"Antioxidants"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1007\/s10620-011-1761-4","volume":"56","author":"Koussoulas V.","year":"2011","unstructured":"Koussoulas V.; Giamarellos-Bourboulis E.J.; Barbatzas C.; Pimentel M.; Serum sTREM-1 as a surrogate marker of treatment outcome in patients with peptic ulcer disease. Dig Dis Sci 2011,56(12),3590-3595","journal-title":"Dig Dis Sci"},{"key":"ref=111","year":"2005","unstructured":"Cytokine gene polymorphisms in gastric diseases 2005"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1523-5378.2008.00593.x","volume":"13","author":"Francavilla R.","year":"2008","unstructured":"Francavilla R.; Lionetti E.; Castellaneta S.P.; Magist&#xE0; A.M.; Maurogiovanni G.; Bucci N.; De Canio A.; Indrio F.; Cavallo L.; Ierardi E.; Miniello V.L.; Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: A pilot study. Helicobacter 2008,13(2),127-134","journal-title":"Helicobacter"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.3748\/wjg.v18.i45.6521","volume":"18","author":"Chai J.","year":"2012","unstructured":"Chai J.; Jamal M.M.; Esophageal malignancy: A growing concern. World J Gastroenterol 2012,18(45),6521-6526","journal-title":"World J Gastroenterol"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530322666220829142124","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208172\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530322666220829142124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T05:06:56Z","timestamp":1689656816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208172\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530322666220829142124","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}